Overview

Combination Chemotherapy in Treating Women With Breast Cancer

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them after surgery may kill any remaining tumor cells following surgery. It is not yet known which combination chemotherapy regimen is more effective in treating breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two different combination chemotherapy regimens in treating women who have primary breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Treatments:
Cyclophosphamide
Docetaxel
Epirubicin
Fluorouracil
Goserelin
Tamoxifen